Shahin Mohammadi (Founder and Chief Executive Officer), brings over fifteen years of pioneering research at the intersection of artificial intelligence, machine learning, and systems biology. His career spans academic institutions, including MIT and the Broad Institute, as well as industry positions at insitro and GenBio AI, where he developed computational methods for modeling cellular states and biological networks.
Dr. Mohammadi's unique dual perspective as both a research scientist and a patient with lived experience of chronic disease drives his commitment to democratizing healthcare through AI-native tools that enable the earliest and most mechanistic understanding of disease. His technical expertise in translational platform development, combined with his deep knowledge of patient needs, positions him to lead the Foundation's mission of transforming healthcare from reactive treatment to proactive prevention at a global scale.